Cargando…
Current Options in the Treatment of COVID-19: A Review
Novel Coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 in China and spread rapidly all around the world infecting many people. To date, no specific vaccines and drugs have been developed for this disease. Also, due to the COVID-19 pand...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549493/ https://www.ncbi.nlm.nih.gov/pubmed/33116980 http://dx.doi.org/10.2147/RMHP.S265030 |
_version_ | 1783592804627251200 |
---|---|
author | Teimury, Azadeh Mahmoodi Khaledi, Elahe |
author_facet | Teimury, Azadeh Mahmoodi Khaledi, Elahe |
author_sort | Teimury, Azadeh |
collection | PubMed |
description | Novel Coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 in China and spread rapidly all around the world infecting many people. To date, no specific vaccines and drugs have been developed for this disease. Also, due to the COVID-19 pandemic and high prevalence of the infected patients, the drugs and the therapies of other past viral epidemics have been used for this disease. Many studies have been performed on the specific treatments to find whether or not they are effective on COVID-19 patients. In this review, we collected information about the most widely used drugs to treat COVID-19 (coronavirus disease 2019) belonging to groups of antivirals, antibiotics, immune modulators, and anticoagulants. Some of these compounds and drugs were used directly by inpatients, so researchers have examined others in laboratory conditions. This study considered the pros and cons of using these treatments separately and together and compared their results. By studying this review, we hope to provide useful information for researchers. |
format | Online Article Text |
id | pubmed-7549493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-75494932020-10-27 Current Options in the Treatment of COVID-19: A Review Teimury, Azadeh Mahmoodi Khaledi, Elahe Risk Manag Healthc Policy Review Novel Coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 in China and spread rapidly all around the world infecting many people. To date, no specific vaccines and drugs have been developed for this disease. Also, due to the COVID-19 pandemic and high prevalence of the infected patients, the drugs and the therapies of other past viral epidemics have been used for this disease. Many studies have been performed on the specific treatments to find whether or not they are effective on COVID-19 patients. In this review, we collected information about the most widely used drugs to treat COVID-19 (coronavirus disease 2019) belonging to groups of antivirals, antibiotics, immune modulators, and anticoagulants. Some of these compounds and drugs were used directly by inpatients, so researchers have examined others in laboratory conditions. This study considered the pros and cons of using these treatments separately and together and compared their results. By studying this review, we hope to provide useful information for researchers. Dove 2020-10-08 /pmc/articles/PMC7549493/ /pubmed/33116980 http://dx.doi.org/10.2147/RMHP.S265030 Text en © 2020 Teimury and Mahmoodi Khaledi. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Teimury, Azadeh Mahmoodi Khaledi, Elahe Current Options in the Treatment of COVID-19: A Review |
title | Current Options in the Treatment of COVID-19: A Review |
title_full | Current Options in the Treatment of COVID-19: A Review |
title_fullStr | Current Options in the Treatment of COVID-19: A Review |
title_full_unstemmed | Current Options in the Treatment of COVID-19: A Review |
title_short | Current Options in the Treatment of COVID-19: A Review |
title_sort | current options in the treatment of covid-19: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549493/ https://www.ncbi.nlm.nih.gov/pubmed/33116980 http://dx.doi.org/10.2147/RMHP.S265030 |
work_keys_str_mv | AT teimuryazadeh currentoptionsinthetreatmentofcovid19areview AT mahmoodikhaledielahe currentoptionsinthetreatmentofcovid19areview |